[1]
Hickling, D. 2024. MV140 sublingual vaccine proves promising in fighting recurrent urinary tract infections in women. Canadian Urological Association Journal. 18, 2 (Jan. 2024), 32. DOI:https://doi.org/10.5489/cuaj.8716.